MX2007005356A - Terapia de combinacion que comprende zd6474 y un antiadrogenico. - Google Patents
Terapia de combinacion que comprende zd6474 y un antiadrogenico.Info
- Publication number
- MX2007005356A MX2007005356A MX2007005356A MX2007005356A MX2007005356A MX 2007005356 A MX2007005356 A MX 2007005356A MX 2007005356 A MX2007005356 A MX 2007005356A MX 2007005356 A MX2007005356 A MX 2007005356A MX 2007005356 A MX2007005356 A MX 2007005356A
- Authority
- MX
- Mexico
- Prior art keywords
- antiandrogen
- human
- antiangiogenic
- warm
- treated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion se refiere a un metodo para la produccion de un efecto antiangiogenico y/o reductor de al permeabilidad vascular, en un animal de sangre caliente tal como un ser humano, que opcionalmente esta siendo tratado con radiacion ionizante, particularmente un metodo para el tratamiento de un cancer, particularmente un cancer que involucra un tumo solido, que comprende la administracion de ZD6474 en combinacion con ablacion androgenica; a una composicion farmaceutica que compre de ZD6474 y un antiandrogenico, para utilizarse en un metodo de tratamiento del cuerpo de un ser humano o un animal por terapia; a un paquete que comprende ZD6474 y un antiandrogenico; al uso de ZD6474 y un antiandrogenico en la manufactura de un medicamento para utilizarse en la produccion de un efecto antiangiogenico y/o reductor de la permeabilidad vascular, en una animal de sangre caliente tal como un ser humano que opcionalmente esta siendo tratado con radiacion ionizante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424339A GB0424339D0 (en) | 2004-11-03 | 2004-11-03 | Combination therapy |
PCT/GB2005/004220 WO2006048633A2 (en) | 2004-11-03 | 2005-11-01 | Combination comprising zd6474 and an antiandrogen |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007005356A true MX2007005356A (es) | 2007-06-18 |
Family
ID=33523132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007005356A MX2007005356A (es) | 2004-11-03 | 2005-11-01 | Terapia de combinacion que comprende zd6474 y un antiadrogenico. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080200436A1 (es) |
EP (1) | EP1817038A2 (es) |
JP (1) | JP2008519019A (es) |
KR (1) | KR20070091119A (es) |
CN (1) | CN101094673A (es) |
AU (1) | AU2005302761B2 (es) |
BR (1) | BRPI0517953A (es) |
CA (1) | CA2583570A1 (es) |
GB (1) | GB0424339D0 (es) |
IL (1) | IL182469A0 (es) |
MX (1) | MX2007005356A (es) |
NO (1) | NO20072167L (es) |
WO (1) | WO2006048633A2 (es) |
ZA (1) | ZA200703526B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
GB0126879D0 (en) * | 2001-11-08 | 2002-01-02 | Astrazeneca Ab | Combination therapy |
GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
GB0223380D0 (en) * | 2002-10-09 | 2002-11-13 | Astrazeneca Ab | Combination therapy |
NZ541297A (en) * | 2003-02-13 | 2008-03-28 | Astrazeneca Ab | Combination therapy of ZD6474 with 5-FU or/and CPT-11 |
GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
KR20120093411A (ko) * | 2003-07-10 | 2012-08-22 | 아스트라제네카 아베 | 백금 화합물 및 임의적으로 이온화 방사능과 조합된 퀴나졸린 유도체 zd6474의 혈관신생 및/또는 증가된 혈관 투과성 관련 질환 치료 용도 |
GB0318422D0 (en) * | 2003-08-06 | 2003-09-10 | Astrazeneca Ab | Chemical compounds |
AU2005288737B2 (en) * | 2004-09-27 | 2008-08-14 | Astrazeneca Ab | Combination comprising ZD6474 and imatinib |
PT1971338E (pt) * | 2005-12-22 | 2011-05-09 | Astrazeneca Ab | Combina??o de zd6474 e pemetrexed |
WO2008037996A1 (en) | 2006-09-29 | 2008-04-03 | Astrazeneca Ab | Combination of zd6474 and bevacizumab for cancer therapy |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US629180A (en) * | 1898-11-21 | 1899-07-18 | Decatur Car Wheel And Mfg Company | Journal-box. |
JPH08163594A (ja) * | 1994-12-12 | 1996-06-21 | Sony Corp | 動画像復号化方法及び動画像復号化装置 |
GB9607633D0 (en) * | 1996-04-12 | 1996-06-12 | Discreet Logic Inc | Grain matching of composite image in image |
GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
UA72946C2 (uk) * | 1999-11-05 | 2005-05-16 | Астразенека Аб | Похідні хіназоліну як інгібітори васкулярного ендотеліального фактора росту (vegf) |
TWI310684B (en) * | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
GB0008368D0 (en) * | 2000-04-06 | 2000-05-24 | Astrazeneca Ab | Combination product |
US20030114519A1 (en) * | 2000-05-23 | 2003-06-19 | Barrington Furr | Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition |
GB0012291D0 (en) * | 2000-05-23 | 2000-07-12 | Astrazeneca Ab | Pharmaceutical combination |
JP2001357090A (ja) * | 2000-06-13 | 2001-12-26 | Hitachi Ltd | 論理合成方法及び論理合成装置 |
EP1324754A1 (en) * | 2000-07-05 | 2003-07-09 | AstraZeneca AB | Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
SE0101697D0 (sv) * | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Pharmaceutical combination |
RU2004108695A (ru) * | 2001-08-24 | 2005-08-20 | Конинклейке Филипс Электроникс Н.В. (Nl) | Суммирование полей видеокадра |
GB0126879D0 (en) * | 2001-11-08 | 2002-01-02 | Astrazeneca Ab | Combination therapy |
SE0103839D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Pharmaceutical formulation & product |
US7065255B2 (en) * | 2002-05-06 | 2006-06-20 | Eastman Kodak Company | Method and apparatus for enhancing digital images utilizing non-image data |
GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
JP2006502132A (ja) * | 2002-08-09 | 2006-01-19 | アストラゼネカ アクチボラグ | 癌の治療における血管内皮細胞増殖因子受容体の阻害薬zd6474と放射線療法との併用 |
GB0223380D0 (en) * | 2002-10-09 | 2002-11-13 | Astrazeneca Ab | Combination therapy |
NZ541297A (en) * | 2003-02-13 | 2008-03-28 | Astrazeneca Ab | Combination therapy of ZD6474 with 5-FU or/and CPT-11 |
RU2005139131A (ru) * | 2003-05-15 | 2006-06-10 | Томсон Лайсенсинг (Fr) | Способ и устройство для представления зернистости изображения посредством одного или нескольких параметров |
KR20120093411A (ko) * | 2003-07-10 | 2012-08-22 | 아스트라제네카 아베 | 백금 화합물 및 임의적으로 이온화 방사능과 조합된 퀴나졸린 유도체 zd6474의 혈관신생 및/또는 증가된 혈관 투과성 관련 질환 치료 용도 |
JP2005080301A (ja) * | 2003-09-01 | 2005-03-24 | Matsushita Electric Ind Co Ltd | 動画像符号化方法および動画像復号化方法 |
AU2005288737B2 (en) * | 2004-09-27 | 2008-08-14 | Astrazeneca Ab | Combination comprising ZD6474 and imatinib |
KR101218242B1 (ko) * | 2004-10-18 | 2013-01-04 | 톰슨 라이센싱 | 필름 그레인 시뮬레이션을 위한 방법, 장치 및 시스템 |
US20060082649A1 (en) * | 2004-10-18 | 2006-04-20 | Cristina Gomila | Film grain simulation method |
KR101174179B1 (ko) * | 2004-10-21 | 2012-08-16 | 톰슨 라이센싱 | 블록 기반의 필름 그레인 패턴의 적응적 디블로킹을 위한기술 |
US7432986B2 (en) * | 2005-02-16 | 2008-10-07 | Lsi Corporation | Method and apparatus for masking of video artifacts and/or insertion of film grain in a video decoder |
PT1971338E (pt) * | 2005-12-22 | 2011-05-09 | Astrazeneca Ab | Combina??o de zd6474 e pemetrexed |
-
2004
- 2004-11-03 GB GB0424339A patent/GB0424339D0/en not_active Ceased
-
2005
- 2005-11-01 WO PCT/GB2005/004220 patent/WO2006048633A2/en active Application Filing
- 2005-11-01 BR BRPI0517953-0A patent/BRPI0517953A/pt not_active IP Right Cessation
- 2005-11-01 KR KR1020077011982A patent/KR20070091119A/ko not_active Application Discontinuation
- 2005-11-01 US US11/666,762 patent/US20080200436A1/en not_active Abandoned
- 2005-11-01 AU AU2005302761A patent/AU2005302761B2/en not_active Expired - Fee Related
- 2005-11-01 CN CNA2005800453975A patent/CN101094673A/zh active Pending
- 2005-11-01 MX MX2007005356A patent/MX2007005356A/es not_active Application Discontinuation
- 2005-11-01 JP JP2007539629A patent/JP2008519019A/ja active Pending
- 2005-11-01 EP EP05800027A patent/EP1817038A2/en not_active Withdrawn
- 2005-11-01 CA CA002583570A patent/CA2583570A1/en not_active Abandoned
-
2007
- 2007-04-11 IL IL182469A patent/IL182469A0/en unknown
- 2007-04-26 NO NO20072167A patent/NO20072167L/no not_active Application Discontinuation
- 2007-05-02 ZA ZA200703526A patent/ZA200703526B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008519019A (ja) | 2008-06-05 |
NO20072167L (no) | 2007-05-22 |
WO2006048633A2 (en) | 2006-05-11 |
EP1817038A2 (en) | 2007-08-15 |
CA2583570A1 (en) | 2006-05-11 |
GB0424339D0 (en) | 2004-12-08 |
AU2005302761A1 (en) | 2006-05-11 |
ZA200703526B (en) | 2008-09-25 |
BRPI0517953A (pt) | 2008-10-21 |
IL182469A0 (en) | 2007-07-24 |
AU2005302761B2 (en) | 2009-06-25 |
WO2006048633A3 (en) | 2007-02-08 |
US20080200436A1 (en) | 2008-08-21 |
KR20070091119A (ko) | 2007-09-07 |
CN101094673A (zh) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1078771A1 (en) | Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiationin the treatment of cancer | |
MX2007003505A (es) | Combinacion que comprende zd6474 e imatinib. | |
MX2007005356A (es) | Terapia de combinacion que comprende zd6474 y un antiadrogenico. | |
IL191796A0 (en) | Combination of zd6474 and pemetrexed | |
MXPA04004355A (es) | Tratamiento de combinacion que comprende zd6474 y un taxano. | |
HK1123976A1 (en) | Combination of azd2171 and pemetrexed azd2171 | |
HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
HK1096023A1 (en) | Combination therapy with azd2171 and 5-fu and/or cpt-11 azd2171?5-fu?cpt-11 | |
MXPA05008583A (es) | Terapia de combinacion de zd6474 con 5-fu y/o cpt-11. | |
ZA200600188B (en) | Combination therapy | |
IL177953A0 (en) | Combination therapy including azd2171 and a taxane | |
WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |